185 related articles for article (PubMed ID: 36350759)
21. Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndrome Patients Aged ≥70 Years.
Sandhu KS; Brunstein C; DeFor T; Bejanyan N; Arora M; Warlick E; Weisdorf D; Ustun C
Biol Blood Marrow Transplant; 2016 Feb; 22(2):390-393. PubMed ID: 26415559
[TBL] [Abstract][Full Text] [Related]
22. Poor survival and prediction of prolonged isolated thrombocytopenia post umbilical cord blood transplantation in patients with hematological malignancies.
Wu Y; Zhang Z; Tu M; Pan T; Ding P; Tang B; Wan X; Yao W; Song K; Sun G; Geng L; Qiang P; Liu H; Zhu X; Sun Z
Hematol Oncol; 2022 Feb; 40(1):82-91. PubMed ID: 34664735
[TBL] [Abstract][Full Text] [Related]
23. Impact of Consolidative Unrelated Cord Blood Transplantation on Clinical Outcomes of Patients With Relapsed/Refractory Acute B Lymphoblastic Leukemia Entering Remission Following CD19 Chimeric Antigen Receptor T Cells.
Xu Q; Xue L; An F; Xu H; Wang L; Geng L; Zhang X; Song K; Yao W; Wan X; Tong J; Liu H; Liu X; Zhu X; Zhai Z; Sun Z; Wang X
Front Immunol; 2022; 13():879030. PubMed ID: 35558072
[TBL] [Abstract][Full Text] [Related]
24. Decitabine prior to salvaged cord blood transplantation for acute myeloid leukaemia/myelodysplastic syndrome not in remission.
Yao W; Chu X; Fang X; Zhu X; Tang B; Wan X; Geng L; Tong J; Song K; Zhang X; Qiang P; Sun G; Liu H; Sun Z
J Clin Pharm Ther; 2020 Dec; 45(6):1372-1381. PubMed ID: 33010180
[TBL] [Abstract][Full Text] [Related]
25. Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience.
Patel SA; Allewelt HA; Troy JD; Martin PL; Driscoll TA; Prasad VK; Kurtzberg J; Page KM; Parikh SH
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1722-1728. PubMed ID: 28647558
[TBL] [Abstract][Full Text] [Related]
26. Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients.
Barker JN; Martin PL; Coad JE; DeFor T; Trigg ME; Kurtzberg J; Weisdorf DJ; Wagner J
Biol Blood Marrow Transplant; 2001; 7(7):395-9. PubMed ID: 11529490
[TBL] [Abstract][Full Text] [Related]
27. [Single center comparative analysis of hematopoietic cell transplantation from alternated donor in patients with hematologic malignancies].
Wang J; Zhou J; Zheng HF; Wang PF; Fu CC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):159-65. PubMed ID: 25687066
[TBL] [Abstract][Full Text] [Related]
28. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
Zhang HX; Pang AM; Chen X; Zhang RL; Zhai WH; Ma QL; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):814-822. PubMed ID: 34788920
[No Abstract] [Full Text] [Related]
29. Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT.
Robin M; Sanz GF; Ionescu I; Rio B; Sirvent A; Renaud M; Carreras E; Milpied N; Mohty M; Beguin Y; Bordigoni P; de Witte T; Picardi A; Purtill D; Gluckman E; Kroger N; Rocha V
Leukemia; 2011 Jan; 25(1):75-81. PubMed ID: 20882048
[TBL] [Abstract][Full Text] [Related]
30. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
31. Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome.
Kong J; Gao MG; Qin YZ; Wang Y; Yan CH; Sun YQ; Chang YJ; Xu LP; Zhang XH; Liu KY; Huang XJ; Zhao XS
BMC Cancer; 2022 Jan; 22(1):11. PubMed ID: 34979982
[TBL] [Abstract][Full Text] [Related]
32. Cord blood transplantation for acute leukemia.
Algeri M; Gaspari S; Locatelli F
Expert Opin Biol Ther; 2020 Oct; 20(10):1223-1236. PubMed ID: 32529854
[TBL] [Abstract][Full Text] [Related]
33. Readmissions after Umbilical Cord Blood Transplantation and Impact on Overall Survival.
Crombie J; Spring L; Li S; Soiffer RJ; Antin JH; Alyea EP; Glotzbecker B
Biol Blood Marrow Transplant; 2017 Jan; 23(1):113-118. PubMed ID: 27789360
[TBL] [Abstract][Full Text] [Related]
34. Impact of KIR-ligand mismatch on pediatric T-cell acute lymphoblastic leukemia in unrelated cord blood transplantation.
Kawahara Y; Ishimaru S; Tanaka J; Kako S; Hirayama M; Kanaya M; Ishida H; Sato M; Kobayashi R; Kato M; Goi K; Saito S; Koga Y; Hashii Y; Kato K; Sato A; Atsuta Y; Sakaguchi H
Transplant Cell Ther; 2022 Sep; 28(9):598.e1-598.e8. PubMed ID: 35660064
[TBL] [Abstract][Full Text] [Related]
35. Umbilical cord blood transplantation can overcome the poor prognosis of KMT2A-MLLT3 acute myeloid leukemia and can lead to good GVHD-free/relapse-free survival.
Tong J; Zhang L; Liu H; Xu X; Zheng C; Yao W; Zhu X; Tang B; Wan X; Song K; Zhang X; Sun G; Sun Z
Ann Hematol; 2021 May; 100(5):1303-1309. PubMed ID: 33469688
[TBL] [Abstract][Full Text] [Related]
36. Comparable survival outcomes with haploidentical stem cell transplantation and cord blood transplantation.
Sugita J; Atsuta Y; Nakamae H; Maruyama Y; Ishiyama K; Shiratori S; Fukuda T; Kurata M; Shingai N; Ozawa Y; Masuko M; Nagafuji K; Uchida N; Tanaka M; Onizuka M; Kanda J; Kimura T; Ichinohe T; Teshima T
Bone Marrow Transplant; 2022 Nov; 57(11):1681-1688. PubMed ID: 35987912
[TBL] [Abstract][Full Text] [Related]
37. Allele-Level HLA Matching Impacts Key Outcomes Following Umbilical Cord Blood Transplantation for Inherited Metabolic Disorders.
Mallhi KK; Smith AR; DeFor TE; Lund TC; Orchard PJ; Miller WP
Biol Blood Marrow Transplant; 2017 Jan; 23(1):119-125. PubMed ID: 27989932
[TBL] [Abstract][Full Text] [Related]
38. Umbilical Cord Blood Transplantation after Graft Failure from a Previous Hematopoietic Stem Cell Transplantation.
Volt F; Ruggeri A; Scigliuolo GM; de Latour RP; Bierings M; Al-Seraihy A; Bittencourt H; Labussière-Wallet H; Rocha V; Kenzey C; Cappelli B; Rafii H; Gluckman E; Guerino-Cunha RL
Transplant Cell Ther; 2022 Jan; 28(1):46.e1-46.e7. PubMed ID: 34757218
[TBL] [Abstract][Full Text] [Related]
39. [Unrelated cord blood stem cell transplantation for high-risk/refractory childhood acute myeloid leukemia: a clinical analysis of 160 cases].
Chen EL; Liu HL; Geng LQ; Tang BL; Zhu XY; Yao W; Song KD; Wan X; Sun GY; Qiang P; Fan Q; Zhou ZW; Zheng CC; Zhang L; Zhang XH; Tong J; Sun ZM
Zhonghua Xue Ye Xue Za Zhi; 2021 Jul; 42(7):549-554. PubMed ID: 34455741
[No Abstract] [Full Text] [Related]
40. Haploidentical Hematopoietic Stem Cell Transplantation Versus Umbilical Cord Blood Transplantation in Hematologic Malignancies: A Systematic Review and Meta-Analysis.
Wu R; Ma L
Cell Transplant; 2020; 29():963689720964771. PubMed ID: 33040595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
